ArticleScientific reports2025
Cost and outcome comparison between intradiscal condoliase injection and surgical treatment for lumbar disc herniation based on real-world data analysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intradiscal condoliase injection therapy (ICIT) is a novel minimally invasive treatment for lumbar disc herniation (LDH). We aimed to compare adverse events, outcomes, and costs of ICIT versus surgery using health claims data. From the database for the period 2020 to 2023, 1,982 ICIT, 4,009 endoscopic discectomy, and 5,528 open discectomy records were extracted. Comparing each surgical group matched to the ICIT group revealed that ICIT had a significantly lower surgical site infection incidence (vs. endoscopic, 0.6% vs. 1.4%, P = 0.016; vs. open, 0.6% vs. 2.8%, P < 0.001), whereas the incidence of additional spine surgery within 90 days was significantly higher (4.9% vs. 2.5%, p < 0.001; 4.9% vs. 1.6%, p < 0.001). The total cost of ICIT group was < 50% of that of discectomy (352,271 vs. 807,550 JPY, P < 0.001; 352,271 vs. 866,642 JPY, P < 0.001). In the first month after treatment, ICIT was associated with the least amount of analgesic prescriptions (76.1% vs. 91.2%, P < 0.001; 76.1% vs. 96.2%, P < 0.001), whereas ICIT was associated with the most in the third month (25.6% vs. 16.0%, P < 0.001; 25.6% vs. 15.7%, P < 0.001). ICIT presents a viable, low-cost treatment alternative to surgery for LDH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.